Literature DB >> 5938059

Immunologic deficiency, autoimmune disease, and lymphoma: observations, implications, and speculations.

H H Fudenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5938059     DOI: 10.1002/art.1780090310

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  18 in total

Review 1.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

2.  Hepatocellular carcinoma and lupoid hepatitis (an autopsy study).

Authors:  Y H Xu; R L Peters
Journal:  J Tongji Med Univ       Date:  1986

3.  Tumour development following immunosuppression.

Authors:  A C Allison
Journal:  Proc R Soc Med       Date:  1970-10

Review 4.  Mechanisms in secondary hypogammaglobulinaemia.

Authors:  P G Riches; J R Hobbs
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

5.  [Paraproteins as the product of clonal immune proliferation--a contribution to the immunology and oncology of monoclonal proteins (author's transl)].

Authors:  O Wetter
Journal:  Klin Wochenschr       Date:  1973-09-15

6.  [Immunopathology in Hodgkin's disease].

Authors:  P G Scheurlen
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

7.  Secondary antibody deficiency.

Authors:  J R Hobbs
Journal:  Proc R Soc Med       Date:  1968-09

8.  Serum immunoglobulin levels in children with acute lymphoblastic leukaemia and their mothers and sibs.

Authors:  R K Chandra
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

9.  Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease.

Authors:  J P Cazenave; J A Gagnon; E Girouard; A Bastarache
Journal:  Can Med Assoc J       Date:  1973-10-20       Impact factor: 8.262

10.  Tissue antibodies in idiopathic autoimmune haemolytic anaemia.

Authors:  M A Blajchman
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.